Ping An Capital and Riverhead Capital led a CNY1.291b (approximately USD186m) Series B for China-based biotech startup Lepu Biotech, with participation from SDIC Unity Capital, Haitong Innovation Capital Management, and State New Central Enterprises Operating Investment Fund. Read more